BG37991A3 - Method for stabilizing lyophylized preparation containing beta- lactamic antibiotic - Google Patents

Method for stabilizing lyophylized preparation containing beta- lactamic antibiotic

Info

Publication number
BG37991A3
BG37991A3 BG052598A BG5259881A BG37991A3 BG 37991 A3 BG37991 A3 BG 37991A3 BG 052598 A BG052598 A BG 052598A BG 5259881 A BG5259881 A BG 5259881A BG 37991 A3 BG37991 A3 BG 37991A3
Authority
BG
Bulgaria
Prior art keywords
stabilizing
preparation containing
lyophylized
containing beta
beta
Prior art date
Application number
BG052598A
Other languages
Bulgarian (bg)
English (en)
Inventor
Eizo Hirai
Kazuhiro Shima
Original Assignee
Shionogi & Co.Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co.Ltd. filed Critical Shionogi & Co.Ltd.
Publication of BG37991A3 publication Critical patent/BG37991A3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
BG052598A 1980-06-23 1981-06-23 Method for stabilizing lyophylized preparation containing beta- lactamic antibiotic BG37991A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (1)

Publication Number Publication Date
BG37991A3 true BG37991A3 (en) 1985-09-16

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
BG052598A BG37991A3 (en) 1980-06-23 1981-06-23 Method for stabilizing lyophylized preparation containing beta- lactamic antibiotic

Country Status (31)

Country Link
US (1) US4418058A (enExample)
JP (1) JPS5711909A (enExample)
KR (1) KR840000693B1 (enExample)
AR (1) AR230007A1 (enExample)
AT (1) AT380790B (enExample)
AU (1) AU541627B2 (enExample)
BE (1) BE889351A (enExample)
BG (1) BG37991A3 (enExample)
CA (1) CA1164801A (enExample)
CH (1) CH648210A5 (enExample)
CS (1) CS221835B2 (enExample)
DD (1) DD159879A5 (enExample)
DE (1) DE3124592A1 (enExample)
DK (1) DK158443C (enExample)
ES (1) ES8203887A1 (enExample)
FI (1) FI75490C (enExample)
FR (1) FR2484835A1 (enExample)
GB (1) GB2078737B (enExample)
GR (1) GR75646B (enExample)
HU (1) HU183494B (enExample)
IE (1) IE51331B1 (enExample)
IL (1) IL63136A (enExample)
IT (1) IT1144812B (enExample)
NL (1) NL191777C (enExample)
NO (1) NO156036C (enExample)
NZ (1) NZ197414A (enExample)
PT (1) PT73239B (enExample)
RO (1) RO82720B (enExample)
SE (1) SE460702B (enExample)
YU (1) YU44416B (enExample)
ZA (1) ZA814203B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
RU2003100532A (ru) * 2000-07-13 2004-07-20 Дайити Фармасьютикал Ко., Лтд. (JP) Фармацевтические композиции, содержащие соединение соединения dds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
PL2893929T3 (pl) 2013-03-15 2025-07-21 Merck Sharp & Dohme Llc Kompozycje antybiotykowe ceftolozanu
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (enExample) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
NL7713905A (nl) * 1976-12-17 1978-06-20 Scherico Ltd Werkwijze voor het bereiden van antibioticum- preparaten, alsmede hun toepassing door injec- tie.
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
GR75646B (enExample) 1984-08-02
NO812090L (no) 1981-12-28
ATA278881A (de) 1985-12-15
BE889351A (fr) 1981-10-16
CS221835B2 (en) 1983-04-29
DE3124592C2 (enExample) 1990-12-20
IE51331B1 (en) 1986-12-10
AR230007A1 (es) 1984-02-29
NZ197414A (en) 1984-10-19
CA1164801A (en) 1984-04-03
FR2484835B1 (enExample) 1983-07-01
DK274981A (da) 1981-12-24
FR2484835A1 (fr) 1981-12-24
AT380790B (de) 1986-07-10
ZA814203B (en) 1982-09-29
AU541627B2 (en) 1985-01-17
KR830005848A (ko) 1983-09-14
FI75490C (fi) 1988-07-11
JPS6364405B2 (enExample) 1988-12-12
RO82720B (ro) 1984-07-30
HU183494B (en) 1984-05-28
NL8102943A (nl) 1982-01-18
CH648210A5 (de) 1985-03-15
DE3124592A1 (de) 1982-02-11
NO156036B (no) 1987-04-06
SE8103904L (sv) 1981-12-24
IL63136A0 (en) 1981-09-13
RO82720A (ro) 1984-05-23
IT8167863A0 (it) 1981-06-22
IL63136A (en) 1984-07-31
ES503283A0 (es) 1982-04-01
DK158443C (da) 1990-10-08
YU44416B (en) 1990-08-31
SE460702B (sv) 1989-11-13
FI75490B (fi) 1988-03-31
DD159879A5 (de) 1983-04-13
IT1144812B (it) 1986-10-29
AU7209781A (en) 1983-01-06
IE811347L (en) 1981-12-23
NL191777B (nl) 1996-04-01
US4418058A (en) 1983-11-29
NL191777C (nl) 1996-08-02
ES8203887A1 (es) 1982-04-01
NO156036C (no) 1987-07-15
PT73239B (en) 1982-07-22
DK158443B (da) 1990-05-21
YU157381A (en) 1984-10-31
GB2078737B (en) 1984-03-14
JPS5711909A (en) 1982-01-21
KR840000693B1 (ko) 1984-05-21
FI811948L (fi) 1981-12-24
GB2078737A (en) 1982-01-13
PT73239A (en) 1981-07-01

Similar Documents

Publication Publication Date Title
BG34615A3 (bg) Метод за получаване на 1- окиси на пеницилановата киселина
IT8320723A0 (it) Composto dell'acido fosfinilmetilamminocarbonilimminico.
BG37991A3 (en) Method for stabilizing lyophylized preparation containing beta- lactamic antibiotic
NZ192046A (en) Cementitious composition comprising an acid formate of ammonium, sodium or potassium as an accelerator
FR2557878B1 (fr) Compose antibiotique, procede pour le preparer et compositions le contenant
BG32851A3 (bg) Метод за получаване на 3,4,5,6-тетрахидро-2н- -1-бензоксецини
ES8207584A1 (es) Procedimiento para el desdoblamiento enzimatico de acido d, l-2-amino-4-metilfosfinobutirico.
BG41126A3 (en) Method for preparing benzamides
BG41822A3 (en) Method for preparing pyridyl derivatives
BG42835A3 (bg) Метод за получаване на производни на тиазолилоцетна киселина
JPS5430197A (en) Novel antibiotic compound
BG40148A3 (bg) Метод за получаване на хетероциклично съединение
ES8603193A1 (es) Procedimiento para preparar nuevos esteres de estriol
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
FI823360A7 (fi) Uudet 3-fenyyli-1-indanamiinit ja menetelmä niiden valmistamiseksi ja niitä sisältävät koostumukset.
BR8107888A (pt) Composicoes herbicidas,baseadas em derivados de acido 2'-fenilhidrazino-acrilico
BG33288A3 (en) Method for obtaining of 6- methyl- 8 (substituated)- methylergolin
BG35045A3 (bg) Метод за получаване на заместени триарилтиазолови съединения
BG35896A3 (en) Method for preparing 3- halogen- 3- cephem compounds
BG40653A3 (en) Method for preparing amidothiocarbamate derivatives of carbon acid
BG35895A3 (en) Method for preparing of n- substituted- 2- haloacetanilides
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
BG41128A3 (en) Method for prepparing intermediary compounds for preparation of benzothiazine- carboxamides
IT8024975A0 (it) Preparazione di acido 2,5-dichetogluconico.
ES8701182A1 (es) Un procedimiento para preparar sal monosodica del acido 7-d-mandelamido-3-(1-sulfometiltetrazol-5-il)tiometil-3-cefem-4-carboxilico